These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4158798)

  • 1. Anaphylatoxin formation by purified human C'1 esterase.
    Dias da Silva W; Lepow IH
    J Immunol; 1965 Dec; 95(6):1080-9. PubMed ID: 4158798
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.
    Dias Da Silva W; Lepow IH
    J Exp Med; 1967 May; 125(5):921-46. PubMed ID: 4960742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.
    RATNOFF OD; LEPOW IH
    J Exp Med; 1963 Nov; 118(5):681-98. PubMed ID: 14087615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.
    Klemperer MR; Donaldson VH; Rosen FS
    J Clin Invest; 1968 Mar; 47(3):604-11. PubMed ID: 4170149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENHANCEMENT OF VASCULAR PERMEABILITY BY MIXTURES OF C'1 ESTERASE AND NORMAL SERUM.
    SMINK RD; ABERNETHY RW; RATNOFF OD; LEPOW IH
    Proc Soc Exp Biol Med; 1964 Jun; 116():280-3. PubMed ID: 14193359
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of human anaphylatoxin C3a with rat mast cells demonstrated by immunofluorescence.
    ter Laan B; Molenaar JL; Feltkamp-Vroom TM; Pondman KW
    Eur J Immunol; 1974 May; 4(5):393-5. PubMed ID: 4136830
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunochemical and biologic properties of rat IgE. II. Capacity to mediate the immunologic releas of histamine an slow-reacting substance of anaphylaxis (SRS-A).
    Orange RP; Stechschulte DJ; Austen KF
    J Immunol; 1970 Nov; 105(5):1087-95. PubMed ID: 4099046
    [No Abstract]   [Full Text] [Related]  

  • 9. The conversion of C'IS to C'1 esterase by plasmin and trypsin.
    Ratnoff OD; Naff GB
    J Exp Med; 1967 Feb; 125(2):337-58. PubMed ID: 4225264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.
    Ratnoff OD; Pensky J; Ogston D; Naff GB
    J Exp Med; 1969 Feb; 129(2):315-31. PubMed ID: 4178758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of anaphylatoxin (AT) upon capillary permeability in guinea pig skin].
    Bodammer G; Vogt W
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(3):255-60. PubMed ID: 4193283
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON HUMAN C'1-ESTERASE. II. FUNCTION OF PURIFIED C'1-ESTERASE IN THE HUMAN COMPLEMENT SYSTEM.
    HAINES AL; LEPOW IH
    J Immunol; 1964 Mar; 92():468-78. PubMed ID: 14131465
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.
    Austen KF; Becker EL
    J Exp Med; 1966 Sep; 124(3):397-416. PubMed ID: 4162486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous responses to human C 3 anaphylatoxin in man.
    Wuepper KD; Bokisch VA; Müller-Eberhard HJ; Stoughton RB
    Clin Exp Immunol; 1972 May; 11(1):13-20. PubMed ID: 4114148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction mechanisms in the release of mediators of immediate hypersensitivity from human lung tissue.
    Austen KF
    Fed Proc; 1974 Nov; 33(11):2256-62. PubMed ID: 4139041
    [No Abstract]   [Full Text] [Related]  

  • 17. [Histamine-independent effects of anaphylatoxin on smooth muscle of isolated organs].
    Vogt W; Zeman N; Garbe G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(4):399-404. PubMed ID: 4180716
    [No Abstract]   [Full Text] [Related]  

  • 18. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.
    MUELLER-EBERHARD HJ; LEPOW IH
    J Exp Med; 1965 May; 121(5):819-33. PubMed ID: 14280442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    Cochrane CG; Müller-Eberhard HJ
    J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.
    DONALDSON VH; ROSEN FS
    J Clin Invest; 1964 Nov; 43(11):2204-13. PubMed ID: 14223932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.